Gestational diabetes mellitus (GDM) patients have lower plasma oxytocin levels than healthy pregnant women, and oxytocin antagonists can impair insulin secretion and lead to the development of GDM symptoms in pregnant mice (190). This evidence concerns the gene INS and gestational diabetes.